Diabetes & Metabolism Journal

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Real-World Prescription Patterns and Barriers Related to the Use of Sodium-Glucose Cotransporter 2 Inhibitors among Korean Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease

Jong Ha Baek, Ye Seul Yang, Seung-Hyun Ko, Kyung Do Han, Jae Hyeon Kim, Min Kyong Moon, Jong Suk Park, Byung-Wan Lee, Tae Jung Oh, Suk Chon, Jong Han Choi, Kyu Yeon Hur, ,

Diabetes Metab J. 2022;46(5):701-712. Published online June 3, 2022
DOI: https://doi.org/10.4093/dmj.2022.0002

Real-World Prescription Patterns and Barriers Related to the Use of Sodium-Glucose Cotransporter 2 Inhibitors among Korean Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease

Jong Ha Baek, Ye Seul Yang, Seung-Hyun Ko, Kyung Do Han, Jae Hyeon Kim, Min Kyong Moon, Jong Suk Park, Byung-Wan Lee, Tae Jung Oh, Suk Chon, Jong Han Choi, Kyu Yeon Hur, ,

Diabetes & Metabolism Journal. 2022;46(5):701-712

Link1

Link2 Link3

160-LB: Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Hemodynamic and Metabolic Cardiovascular Markers in Patients with Type 2 Diabetes Mellitus

NATTAPOL SATHAVARODOM

Diabetes. 2019;68(Supplement_1):

Link1 Link2

Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Korean Patients with Type 2 Diabetes Mellitus in Real-World Clinical Practice

A Ram Hong, Bo Kyung Koo, Sang Wan Kim, Ka Hee Yi, Min Kyong Moon

Diabetes & Metabolism Journal. 2019;43(5):590

Link1 Link2 Link3

Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Cardiovascular Outcomes in Patients with Diabetes Mellitus and Heart Failure

Felix Hofer, Niema Kazem, Bernhard Richter, Patrick Sulzgruber, Ronny Schweitzer, Ulrike Pailer, Andreas Hammer, Lorenz Koller, Christian Hengstenberg, Alexander Niessner

Cardiovascular Drugs and Therapy. 2021;36(3):497-504

Link1

Link2 Link3

Role of sodium-glucose cotransporter-2 inhibitors in risk of chronic kidney disease among patients with type 2 diabetes mellitus

Tung-Sheng Chen, Teng-Shun Yu, Cheng-Li Lin, Chung Y. Hsu, Wei-Syun Hu

Journal of Nephrology. 2022;

Link1

Link2 Link3

Sodium-Glucose Cotransporter-2 Inhibitors Ameliorate Liver Enzyme Abnormalities in Korean Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease

Won Euh, Soo Lim, Jin-Wook Kim

Frontiers in Endocrinology. 2021;12:

Link1

Demographic and clinical characteristics of patients with type 1 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors in Japan: A real-world administrative database analysis

Norio Abiru, Shingo Shoji, Yoshinori Kosakai, Robert Snijder, Keiko Asakawa, Mitsuhiro Rokuda

Diabetes Research and Clinical Practice. 2022;190:109973

Link1 Link2

Cardiovascular Safety of Sodium Glucose Cotransporter 2 Inhibitors as Add-on to Metformin Monotherapy in Patients with Type 2 Diabetes Mellitus

Ja Young Jeon, Kyoung Hwa Ha, Dae Jung Kim

Diabetes & Metabolism Journal. 2021;45(4):505-514

Link1

Link2 Link3

The association of amputations and peripheral artery disease in patients with type 2 diabetes mellitus receiving sodium-glucose cotransporter type-2 inhibitors: real-world study

Sanjoy K Paul, Deepak L Bhatt, Olga Montvida

European Heart Journal. 2020;42(18):1728-1738

Link1

Link2

Real-World Treatment Patterns of Glucose-Lowering Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease or At Risk for Cardiovascular Disease: An Observational, Cross-Sectional, Retrospective Study

Radhika Nair, Reema Mody, Maria Yu, Stuart Cowburn, Manige Konig, Todd Prewitt

Diabetes Therapy. 2022;13(11-12):1921-1932

Link1

Link2 Link3